MacroGenics, Inc. (MGNX)

3.74 -0.06 (-1.58%) USD  |  NASDAQ  |  Sep 25, 16:00
3.75 +0.01 (+0.27%) After-Hours: 19:59
More

MacroGenics Cash and Short Term Investments (Annual) : 189.91M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for MGNX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2011. Start Trial.
Date Value
December 31, 2025 189.91M
December 31, 2024 201.67M
December 31, 2023 229.80M
December 31, 2022 154.35M
December 31, 2021 243.62M
December 31, 2020 272.53M
December 31, 2019 215.76M
December 31, 2018 232.86M
Date Value
December 31, 2017 305.12M
December 31, 2016 277.00M
December 31, 2015 339.05M
December 31, 2014 157.59M
December 31, 2013 116.48M
December 31, 2012 47.74M
December 31, 2011 55.22M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Gilead Sciences, Inc. 9.613B
Xencor, Inc. 547.73M
ACADIA Pharmaceuticals, Inc. 819.69M
Alnylam Pharmaceuticals, Inc. 2.908B
Anika Therapeutics, Inc. 57.48M